Thyrotropin-producing pituitary adenoma simultaneously existing with Graves’ disease: a case report
Open Access
- 6 January 2017
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 11 (1) , 1-5
Abstract
Thyrotropin-producing pituitary tumor is relatively rare. In particular, concurrent cases associated with Graves’ disease are extremely rare and only nine cases have been reported so far. We describe a case of a thyrotropin-producing pituitary adenoma concomitant with Graves’ disease, which was successfully treated. A 40-year-old Japanese woman presented with mild signs of hyperthyroidism. She had positive anti-thyroid-stimulating hormone receptor antibody, anti-thyroglobulin antibody, and anti-thyroid peroxidase antibody. Her levels of serum thyroid-stimulating hormone, which ranged from low to normal in the presence of high levels of serum free thyroid hormones, were considered to be close to a state of syndrome of inappropriate secretion of thyroid-stimulating hormone. Magnetic resonance imaging showed a macropituitary tumor. The coexistence of thyrotropin-producing pituitary adenoma and Graves’ disease was suspected. Initial therapy included anti-thyroid medication, which was immediately discontinued due to worsening symptoms. Subsequently, surgical therapy for the pituitary tumor was conducted, and her levels of free thyroid hormones, including the thyroid-stimulating hormone, became normal. On postoperative examination, her anti-thyroid-stimulating hormone receptor antibody levels decreased, and the anti-thyroglobulin antibody became negative. The coexistence of thyrotropin-producing pituitary adenoma and Graves’ disease is rarely reported. The diagnosis of this condition is complicated, and the appropriate treatment strategy has not been clearly established. This case suggests that physicians should consider the coexistence of thyrotropin-producing pituitary adenoma with Graves’ disease in cases in which thyroid-stimulating hormone values range from low to normal in the presence of thyrotoxicosis, and the surgical treatment of thyrotropin-producing pituitary adenoma could be the first-line therapy in patients with both thyrotropin-producing pituitary adenoma and Graves’ disease.Keywords
This publication has 14 references indexed in Scilit:
- Coexistence of Thyroid-Stimulating Hormone-Secreting Pituitary Adenoma and Graves' HyperthyroidismEuropean Thyroid Journal, 2013
- Thyroid-stimulating hormone-secreting pituitary adenoma presenting with recurrent hyperthyroidism in post-treated Graves’ disease: a case reportJournal of Medical Case Reports, 2013
- Concomitant Graves Hyperthyroidism with Thyrotrophin-Secreting Pituitary AdenomaSouthern Medical Journal, 2010
- A case of atypical thyrotroph cell adenoma, which re-grew within 3 months after surgery and required multimodal treatmentJournal of Neuro-Oncology, 2007
- Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literatureEuropean Journal of Endocrinology, 2007
- Thyrotropin-Secreting Pituitary Tumors*Endocrine Reviews, 1996
- Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged womanEuropean Journal of Endocrinology, 1985
- A NEW STRATEGY FOR THYROID FUNCTION TESTINGThe Lancet, 1985
- Inappropriate Secretion of Thyroid-Stimulating HormoneAnnals of Internal Medicine, 1981
- Recurrent Hyperthyroidism in an Acromegalic Patient Previously Treated with Proton Beam Irradiation: Graves’ Disease as Probable Etiology Based on Follow-Up ObservationsThe Journal of Clinical Endocrinology & Metabolism, 1976